About Edward Lasater
Form D filings for Cx Precision Medicine from 2020 to 2024 list Edward Lasater as director.
Edward Lasater first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Edward Lasater in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Edward Lasater works with at each company, as listed on that company's latest Form D.
Cx Precision Medicine, Inc. · Form D, Jun 26, 2024
DB
Darlene Boudreaux
Executive officer
CC
Cameron Cushman
Director
RF
Robert Ferguson
Director
DA
Danguole Altman
President and CEO, director
DK
Donald Keyser
Director